Gilead Sciences Ireland UC filed an extension (TTAB99031163-20260405) in the Trademark Trial and Appeal Board proceeding concerning the VOCEMIVY trademark. The defendant is Vertex Pharmaceuticals Incorporated. The filing date is October 29, 2025. The abstract indicates a plaintiff change of correspondence information.

This is a routine procedural filing within an existing trademark dispute. No compliance actions are required from unrelated third parties. Parties to the case should ensure their correspondence information remains current and monitor for further TTAB deadlines.